News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
Boston-based NanoView aims to make its extracellular vesicle detection technology more widely available for research and biomarker discovery.
The firm said current adoption is robust, but enabling readout on NGS instruments this summer will be crucial to opening a much larger customer base.
The firm said it took in $33.6 million in product and service revenue in the quarter, a 42 percent increase from $23.6 million in Q4 2018.
Although polygenic risk scores for coronary artery disease can slightly improve standard risk assessment tools, the predicted clinical impact remains small.
With data from UK Biobank participants, investigators identified dozens of snoring-related genetic loci and links to traits such as weight, smoking, and sleep apnea.
According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.
A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.
Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.
In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.
This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.
This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.